Skip to content

The Roles of IL-9/E-cadherin and Ferroptosis in Intestinal Mucosal Barrier Injury in Sepsis

The Roles of IL-9/E-cadherin and Ferroptosis in Intestinal Mucosal Barrier Injury in Sepsis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05410665
Enrollment
100
Registered
2022-06-08
Start date
2022-05-31
Completion date
2024-06-30
Last updated
2022-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ferroptosis, Intestinal Mucosal Barrier, Sepsis

Brief summary

The investigators aim to evaluate the roles of IL-9/E-cadheirin and ferroptosis in the intestinal mucosal barrier injury of sepsis. The results of this study would lay the foundation for revealing the mechanisms of EEN improving immune imbalance of sepsis and provide a new idea to the early treatment of sepsis.

Interventions

PROCEDUREStandard treatments for sepsis

Standard treatments for others

Sponsors

Nanjing First Hospital, Nanjing Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Clinical diagnosis of sepsis 2. Within 3 days of sepsis onset before ICU admission 3. No artificial nutrition (enteral or parenteral nutrition) were provided before ICU admission

Exclusion criteria

1. Ileus 2. Digestive tract hemorrhage 3. Inflammatory bowel disease 4. Cancer or chronic organ dysfunction (e.g., hepatic or renal dysfunction) 5. Malnutrition or immunodeficiency 6. Long-term use of hormones

Design outcomes

Primary

MeasureTime frameDescription
Incidence of intestinal barrier injury incidence of intestinal barrier injury7 daysintestinal barrier injury

Secondary

MeasureTime frameDescription
Incidence of ferroptosis7 daysferroptosis

Countries

China

Contacts

Primary ContactJie Zhou, Dr.
565219791@qq.com+8613913893984

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026